StemCells, Inc. Appoints R. Scott Greer to Board of Directors
08 juin 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., June 8, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the appointment of R. Scott Greer to its Board of Directors. Mr. Greer is a successful entrepreneur...
StemCells, Inc. Grants Research License to Children's Hospital of Orange County
03 juin 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif. and ORANGE, Calif., June 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) (the "Company") and the Children's Hospital of Orange County ("CHOC Children's") announced today...
StemCells, Inc. to Present at Two Investor Conferences
27 mai 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., May 27, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Chief Financial Officer Rodney Young will present at two upcoming investor conferences taking...
StemCells, Inc. Management to Present at World Stem Cells and Regenerative Medicine Congress
06 mai 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., May 6, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, President and CEO, and Stewart Craig, Ph.D., Senior Vice President, Development...
StemCells, Inc. Reports First Quarter Financial Results and Highlights
04 mai 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., May 4, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell technology company with the dual focus of novel therapeutics and innovative research products,...
StemCells, Inc.'s Phase I Batten Trial Data Featured at American Association of Neurological Surgeons Annual Meeting
03 mai 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., May 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced that Nathan Selden, M.D., Ph.D., F.A.C.S., F.A.A.P., will give a feature presentation today at the American...
StemCells, Inc. Plans to Advance to Second Clinical Trial in Batten Disease
21 avr. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., April 21, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has submitted a protocol to the FDA for initiation of a second clinical trial of its...
StemCells, Inc. Granted Broad Patent for Pluripotent Rat Stem Cells and Genetically Engineered Rats
17 mars 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 17, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the United Kingdom (UK) Intellectual Property Office has granted patent number GB2451523 with...
StemCells, Inc. Reports Fourth Quarter and Fiscal 2009 Financial Results
11 mars 2010 06h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., March 11, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today reported financial results for the fourth quarter and year ended December 31, 2009. The Company's results...
StemCells, Inc. Launches Cell Culture Medium Enabling the Derivation and Maintenance of True Mouse iPS Cells
16 févr. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 16, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of GS2-M™, a new cell culture medium that enables the derivation and long-term...